These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 12665841

  • 1. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N, Donato M, Körbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P.
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [Abstract] [Full Text] [Related]

  • 2. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E, Palangio M, Gonzalez J, Adler KR, Scarborough R, Goldberg SL, Rowley SD.
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [Abstract] [Full Text] [Related]

  • 3. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O, Arat M, Arslan O, Ayyildiz E, Sanli H, Beksac M, Ozcan M, Gürman G, Akan H.
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M, Pessolano R, Albiani R, Asaftei S, Barat V, Carraro F, Biasin E, Madon E, Fagioli F.
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [Abstract] [Full Text] [Related]

  • 8. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
    Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O.
    Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J, Merlin E, Halle P, Paillard C, Marabelle A, Rapatel C, Evrard B, Berger C, Stephan JL, Galambrun C, Piguet C, D'Incan M, Bordigoni P, Deméocq F.
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [Abstract] [Full Text] [Related]

  • 12. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
    Rubegni P, Cuccia A, Sbano P, Cevenini G, Carcagnì MR, D'Ascenzo G, De Aloe G, Guidi S, Guglielmelli P, Marotta G, Lauria F, Bosi A, Fimiani M.
    Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
    [Abstract] [Full Text] [Related]

  • 13. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Ussowicz M, Musiał J, Mielcarek M, Tomaszewska A, Nasiłowska-Adamska B, Kałwak K, Gorczyńska E, Mariańska B, Chybicka A.
    Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
    Perotti C, Del Fante C, Tinelli C, Viarengo G, Scudeller L, Zecca M, Locatelli F, Salvaneschi L.
    Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
    [Abstract] [Full Text] [Related]

  • 16. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P, Feci L, Poggiali S, Marotta G, D'Ascenzo G, Murdaca F, Fimiani M.
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extracorporeal photopheresis in children with graft-versus-host disease.
    Chan KW.
    J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A, Locatelli F, Marmont F, Ceretto C, Falda M.
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [Abstract] [Full Text] [Related]

  • 20. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
    Perseghin P, Galimberti S, Balduzzi A, Bonanomi S, Baldini V, Rovelli A, Dassi M, Rambaldi A, Castagna L, Corti P, Pogliani EM, Uderzo C.
    Ther Apher Dial; 2007 Apr; 11(2):85-93. PubMed ID: 17381528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.